Search Results for: HTR2A

25 interactions involving HTR2A - 5-hydroxytryptamine receptor 2A found:

Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
ANKS1B ankyrin repeat and sterile alpha motif domain containing 1B
ARF1 ADP ribosylation factor 1
  • Synthesis of PIPs at the plasma membrane
  • Synthesis of PIPs at the Golgi membrane
  • Nef Mediated CD4 Down-regulation
  • trans-Golgi Network Vesicle Budding
  • MHC class II antigen presentation
  • Lysosome Vesicle Biogenesis
  • Golgi Associated Vesicle Biogenesis
  • COPI-mediated anterograde transport
  • COPI-dependent Golgi-to-ER retrograde traffic
  • Intra-Golgi traffic
  • Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
  • 1,3-Propanediol
  • Guanosine-3'-monophosphate-5'-diphosphate
  • Guanosine-5'-Triphosphate
  • Guanosine-5'-Diphosphate
  • Brefeldin A
  • Myristic acid
  • Glycerin
ARF6 ADP ribosylation factor 6
  • TBC/RABGAPs
  • Clathrin-mediated endocytosis
  • MET receptor recycling
  • 5'-Guanosine-Diphosphate-Monothiophosphate
  • Guanosine-5'-Diphosphate
  • Myristic acid
CTSG cathepsin G
  • Degradation of the extracellular matrix
  • Activation of Matrix Metalloproteinases
  • Metabolism of Angiotensinogen to Angiotensins
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Interleukin-1 processing
  • Neutrophil degranulation
  • Antimicrobial peptides
  • Suppression of apoptosis
  • Purinergic signaling in leishmaniasis infection
  • Bis-Napthyl Beta-Ketophosphonic Acid
  • 2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid
DACH1 dachshund family transcription factor 1
DIRAS3 DIRAS family GTPase 3
DLG1 discs large MAGUK scaffold protein 1
  • Trafficking of AMPA receptors
  • Unblocking of NMDA receptors, glutamate binding and activation
  • Unblocking of NMDA receptors, glutamate binding and activation
  • Ras activation upon Ca2+ influx through NMDA receptor
  • NrCAM interactions
  • Activation of Ca-permeable Kainate Receptor
  • RAF/MAP kinase cascade
  • Synaptic adhesion-like molecules
  • Assembly and cell surface presentation of NMDA receptors
  • Negative regulation of NMDA receptor-mediated neuronal transmission
  • Long-term potentiation
DLG4 discs large MAGUK scaffold protein 4
  • Signaling by ERBB4
  • Trafficking of AMPA receptors
  • Unblocking of NMDA receptors, glutamate binding and activation
  • Unblocking of NMDA receptors, glutamate binding and activation
  • Ras activation upon Ca2+ influx through NMDA receptor
  • NrCAM interactions
  • Activation of Ca-permeable Kainate Receptor
  • RHO GTPases activate CIT
  • RAF/MAP kinase cascade
  • LGI-ADAM interactions
  • Neurexins and neuroligins
  • Neurexins and neuroligins
  • Synaptic adhesion-like molecules
  • Assembly and cell surface presentation of NMDA receptors
  • Negative regulation of NMDA receptor-mediated neuronal transmission
  • Long-term potentiation
  • Guanidine
  • Guanosine-5'-Monophosphate
EIF3F eukaryotic translation initiation factor 3 subunit F
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Translation initiation complex formation
  • Formation of a pool of free 40S subunits
  • Formation of the ternary complex, and subsequently, the 43S complex
  • Ribosomal scanning and start codon recognition
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Quercetin
GLUL glutamate-ammonia ligase
  • Astrocytic Glutamate-Glutamine Uptake And Metabolism
  • Glutamate and glutamine metabolism
  • L-Glutamine
  • Glutamic acid
GNA11 G protein subunit alpha 11
  • PLC beta mediated events
  • PLC beta mediated events
  • G-protein activation
  • Acetylcholine regulates insulin secretion
  • Acetylcholine regulates insulin secretion
  • G alpha (q) signalling events
  • G alpha (q) signalling events
  • ADP signalling through P2Y purinoceptor 1
  • ADP signalling through P2Y purinoceptor 1
  • Thromboxane signalling through TP receptor
  • Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
  • Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
  • Thrombin signalling through proteinase activated receptors (PARs)
  • Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
GNAI1 G protein subunit alpha i1
  • Adenylate cyclase inhibitory pathway
  • Adenylate cyclase inhibitory pathway
  • ADP signalling through P2Y purinoceptor 12
  • Adrenaline,noradrenaline inhibits insulin secretion
  • Adrenaline,noradrenaline inhibits insulin secretion
  • G alpha (s) signalling events
  • G alpha (i) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
  • Regulation of insulin secretion
  • Extra-nuclear estrogen signaling
  • ADORA2B mediated anti-inflammatory cytokines production
  • Guanosine-5'-Diphosphate
  • Tetrafluoroaluminate Ion
GNAQ G protein subunit alpha q
  • PLC beta mediated events
  • PLC beta mediated events
  • G-protein activation
  • Acetylcholine regulates insulin secretion
  • Acetylcholine regulates insulin secretion
  • G alpha (q) signalling events
  • G alpha (q) signalling events
  • ADP signalling through P2Y purinoceptor 1
  • ADP signalling through P2Y purinoceptor 1
  • Thromboxane signalling through TP receptor
  • Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
  • Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
  • Thrombin signalling through proteinase activated receptors (PARs)
  • Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
JAK2 Janus kinase 2
  • Interleukin-6 signaling
  • Interleukin-6 signaling
  • MAPK3 (ERK1) activation
  • MAPK1 (ERK2) activation
  • Prolactin receptor signaling
  • Prolactin receptor signaling
  • Signaling by SCF-KIT
  • Signaling by Leptin
  • RMTs methylate histone arginines
  • Interleukin-3, Interleukin-5 and GM-CSF signaling
  • Interleukin-3, Interleukin-5 and GM-CSF signaling
  • RAF activation
  • RAF/MAP kinase cascade
  • Interleukin-4 and Interleukin-13 signaling
  • IL-6-type cytokine receptor ligand interactions
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by BRAF and RAF1 fusions
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • Cyclin D associated events in G1
  • Interferon gamma signaling
  • Regulation of IFNG signaling
  • Regulation of IFNG signaling
  • Interleukin-20 family signaling
  • Interleukin-35 Signalling
  • Signaling by Erythropoietin
  • Interleukin-12 signaling
  • Interleukin-12 signaling
  • Interleukin-23 signaling
  • Interleukin-23 signaling
  • Interleukin-27 signaling
  • Interleukin-27 signaling
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Erythropoietin activates Phospholipase C gamma (PLCG)
  • Erythropoietin activates STAT5
  • Erythropoietin activates RAS
  • Erythropoietin activates RAS
  • Interleukin receptor SHC signaling
  • Signaling downstream of RAS mutants
  • Signaling by RAF1 mutants
  • Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants
  • Signaling by CSF3 (G-CSF)
  • Signaling by CSF3 (G-CSF)
  • Potential therapeutics for SARS
  • Inactivation of CSF3 (G-CSF) signaling
  • Inactivation of CSF3 (G-CSF) signaling
  • Growth hormone receptor signaling
  • Growth hormone receptor signaling
  • Factors involved in megakaryocyte development and platelet production
  • 2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one
  • XL019
  • 5-phenyl-1H-indazol-3-amine
  • 4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide
  • 4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM
  • Ruxolitinib
  • Tofacitinib
  • Baricitinib
  • Entrectinib
  • Fostamatinib
  • Fedratinib
  • Zanubrutinib
  • Pralsetinib
MAP1A microtubule associated protein 1A
  • Estramustine
MRPL28 mitochondrial ribosomal protein L28
  • Mitochondrial translation initiation
  • Mitochondrial translation elongation
  • Mitochondrial translation elongation
  • Mitochondrial translation termination
NDUFB10 NADH:ubiquinone oxidoreductase subunit B10
  • Respiratory electron transport
  • Complex I biogenesis
  • NADH
NME3 NME/NM23 nucleoside diphosphate kinase 3
  • Interconversion of nucleotide di- and triphosphates
NTRK3 neurotrophic receptor tyrosine kinase 3
  • Receptor-type tyrosine-protein phosphatases
  • NTF3 activates NTRK3 signaling
  • NTF3 activates NTRK3 signaling
  • Signaling by NTRK3 (TRKC)
  • Activated NTRK3 signals through PLCG1
  • Activated NTRK3 signals through PLCG1
  • Activated NTRK3 signals through RAS
  • Activated NTRK3 signals through PI3K
  • Activated NTRK3 signals through PI3K
  • NTRK3 as a dependence receptor
  • Entrectinib
  • Fostamatinib
  • Larotrectinib
  • Pralsetinib
PCDH9 protocadherin 9
PON2 paraoxonase 2
  • Synthesis of 5-eicosatetraenoic acids
PPP5C protein phosphatase 5 catalytic subunit
  • Negative regulation of MAPK pathway
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • ESR-mediated signaling
  • ATP
RFXAP regulatory factor X associated protein
RPS6KA3 ribosomal protein S6 kinase A3
  • ERK/MAPK targets
  • CREB phosphorylation
  • Senescence-Associated Secretory Phenotype (SASP)
  • Senescence-Associated Secretory Phenotype (SASP)
  • Recycling pathway of L1
  • CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling
  • RSK activation
  • RSK activation
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Acetylsalicylic acid
  • Fostamatinib
SUGT1 SGT1 homolog, MIS12 kinetochore complex assembly cochaperone
  • The NLRP3 inflammasome
  • Purinergic signaling in leishmaniasis infection